Anthropic is making its boldest enterprise push yet with Claude Cowork, rolling out private plug-in marketplaces, deep integrations, and AI agent tools that are reshaping corporate adoption and ...
The Japan International Cooperation Agency (JICA) successfully convened a homecoming presentation session in Accra at the ...
Health Minister Budi Gunadi Sadikin stated that the third batch of the Specialist Doctor Education Program (PPDS) at Teaching ...
HELUS Pharma has rebranded and moved to Nasdaq, signaling a shift toward late-stage clinical development and commercial focus ...
Destroyed servers and DoS attacks: What can happen when OpenClaw AI agents interact ...
In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...
The Japan International Cooperation Agency (JICA) has successfully convened a homecoming presentation session at the Erata ...
Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations.
In synagogue a few days ago, while waiting for the evening prayer to start, we got into a discussion about Mishloah Manot (giving food to friends and family).
CHDN Q4 2025 earnings call highlights: record revenue/EBITDA, $700M free cash flow, HRM expansion and 2026 Derby outlook.
The Japan International Cooperation Agency (JICA) has successfully convened a homecoming presentation session in Accra for Ghanaian government officials who studied in Japan under the Project for ...
Last week, the FDA made its one pivotal trial policy official, sparking myriad questions from industry leaders, including around specific evidence required for the single study and why it hasn’t been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results